XML 56 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segments (Tables)
 9 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Our reporting segments have been determined based on the nature of the products and/or services offered to customers or the nature of their function in the organization. We evaluate performance based on the operating income (loss) contributed by each segment.

Three Months Ended September 30,
 
Nine Months Ended September 30,
(in thousands)
2014
 
2013
 
2014
 
2013
Gross profit by segment:
 
 
 
 
 
 
 
Diagnostic Services
$
2,758

 
$
2,573

 
$
7,915

 
$
6,983

Diagnostic Imaging
1,651

 
1,245

 
4,441

 
3,445

Condensed consolidated gross profit
$
4,409

 
$
3,818

 
$
12,356

 
$
10,428

 
 
 
 
 
 
 
 
Income (loss) from operations by segment:
 
 
 
 
 
 
 
Diagnostic Services
$
167

 
$
396

 
$
275

 
$
(192
)
Diagnostic Imaging (1)
865

 
2,036

 
1,427

 
(417
)
Condensed consolidated income (loss) from operations
$
1,032

 
$
2,432

 
$
1,702

 
$
(609
)
 
 
 
 
 
 
 
 
Depreciation and amortization:
 
 
 
 
 
 
 
Diagnostic Services
$
442

 
$
348

 
$
1,248

 
$
1,095

Diagnostic Imaging
55

 
127

 
193

 
352

Condensed consolidated depreciation and amortization
$
497

 
$
475

 
$
1,441

 
$
1,447
Reconciliation of Assets from Segment to Consolidated
(in thousands)
As of September 30, 2014
 
As of December 31, 2013
Identifiable assets by segment:
 
 
 
Diagnostic Services
$
17,973

 
$
11,874

Diagnostic Imaging
24,195

 
29,577

Condensed Consolidated assets
$
42,168

 
$
41,451

(1) Included in the Diagnostic Imaging income from operations for the three and nine months ended September 30, 2014, are approximately $0.1 million and $0.7 million of charges, respectively, associated with our Diagnostic Imaging and Facilities restructuring initiatives (See Note 7). Included in the Diagnostic Imaging income (loss) from operations for the three and nine months ended September 30, 2013, are approximately $0.1 million and $1.7 million of charges, respectively, associated with our Diagnostic Imaging restructuring initiative, as well as a gain of approximately $1.6 million associated with the sale of assets and licensing agreement from an uncommercialized surgical imaging system previously in development.